Agenus Inc.
(NASDAQ : AGEN)

( )
AGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading AGEN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.80%70.501.0%$928.99m
AMGNAmgen Inc.
0.90%176.130.8%$640.16m
BIIBBiogen Inc.
2.10%291.130.9%$505.62m
CELGCelgene Corporation
3.00%121.781.0%$476.20m
INCYIncyte Corporation
2.14%134.022.3%$444.12m
REGNRegeneron Pharmaceuticals, Inc.
3.34%373.051.9%$336.26m
ALXNAlexion Pharmaceuticals, Inc.
0.50%132.202.0%$304.94m
TSROTESARO, Inc.
0.28%187.4215.3%$167.36m
ILMNIllumina, Inc.
4.26%166.823.9%$151.47m
EXELExelixis, Inc.
6.46%23.095.5%$141.95m
VRTXVertex Pharmaceuticals Incorporated
3.29%88.902.6%$133.58m
CLVSClovis Oncology, Inc.
5.22%60.9216.4%$122.35m
AAgilent Technologies, Inc.
-0.16%51.661.7%$108.92m
BMRNBioMarin Pharmaceutical Inc.
4.70%91.623.9%$100.60m
ACADACADIA Pharmaceuticals Inc.
2.50%39.8519.0%$100.51m

Company Profile

Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.